FDA Drug Application (016235) for TACE by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number016235
Product Number001
FormCAPSULE;ORAL
Dosage72MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTACE
Active IngredientCHLOROTRIANISENE

Active IngredientCount
List of drugs with Active Ingredient CHLOROTRIANISENE2


Back to FDA Applications sponsored by SANOFI AVENTIS US